Palvella Therapeutics (PVLA) Non Operating Income (2016 - 2024)
Historic Non Operating Income for Palvella Therapeutics (PVLA) over the last 11 years, with Q4 2024 value amounting to $641000.0.
- Palvella Therapeutics' Non Operating Income rose 5117.92% to $641000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $685000.0, marking a year-over-year decrease of 379.21%. This contributed to the annual value of $511000.0 for FY2024, which is 2823.03% down from last year.
- Per Palvella Therapeutics' latest filing, its Non Operating Income stood at $641000.0 for Q4 2024, which was up 5117.92% from -$20000.0 recorded in Q3 2024.
- Palvella Therapeutics' 5-year Non Operating Income high stood at $884000.0 for Q1 2021, and its period low was -$1.8 million during Q4 2020.
- Its 5-year average for Non Operating Income is $76210.5, with a median of $229000.0 in 2022.
- In the last 5 years, Palvella Therapeutics' Non Operating Income plummeted by 233454.55% in 2020 and then soared by 157333.33% in 2021.
- Over the past 5 years, Palvella Therapeutics' Non Operating Income (Quarter) stood at -$1.8 million in 2020, then surged by 120.62% to $378000.0 in 2021, then plummeted by 185.98% to -$325000.0 in 2022, then skyrocketed by 230.46% to $424000.0 in 2023, then soared by 51.18% to $641000.0 in 2024.
- Its Non Operating Income was $641000.0 in Q4 2024, compared to -$20000.0 in Q3 2024 and $64000.0 in Q2 2024.